SEC Form 4 · accession 0001209191-15-014538

Inogen Inc · INGN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — EVP, Sales and Marketing

Period of report

Feb 13, 2015

Accepted (ET)

Feb 17, 2015 · 4:39 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001294133

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Feb 13, 2015	M	18,333	$0.60	A	18,333	D
Common Stock^F2	Feb 13, 2015	S	18,333	$32.8716	D	0	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (right to buy)^F3	$0.60	Feb 13, 2015	M	18,333	D	—	Feb 24, 2020	Common Stock	18,333	6,372	D

F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 17, 2014.
F2Represents the weighted average share price of an aggregate total of 18333 shares sold in the price range of $32.50 to $33.58 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3Subject to the reporting person's continuing service, thirty nine percent (39%) of the shares subject to the option shall vest and become exercisable on the vesting commencement date, and thereafter, one thirtieth (1/30th) of the remaining shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the thirty (30) month anniversary of the vesting commencement date. The vesting commencement date for this option is February 24, 2010.